No segmentation disclosed for this filer. n/a
RBC Life Sciences, Inc. booked $25.8M in FY2016 revenue, growing 5.8% year over year — about the middle of the pack among Healthcare companies we track, at a -2.9% net margin.
No filings loaded — no CIK (non-SEC filer).